Under construction – not a live service
Sign in
Taking peopleNo phase

Studying Gene Changes Linked to Autoimmune Diseases in Peru

Studies gene changes that may lead to autoimmune diseases in adults native to Peru.

Plain-language title generated from the registry record
Registry title: Deciphering the Genetic Architecture of Autoimmune Diseases

Key facts

Where
Bethesda, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 115 years old?

Source: NCT06948110, who can take part

Where in United States

  • National Human Genome Research Institute (NHGRI)Bethesda, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
National Human Genome Research Institute (NHGRI)
Trial code
NCT06948110
Record updated
10 November 2026
Original description
Background:Read full original descriptionShow less

Deciphering the Genetic Architecture of Autoimmune Diseases

Background:

Autoimmune diseases can be caused by genes people inherit from their parents. The gene changes that cause these diseases have been well studied in people with European and Asian ancestors. But some diseases behave differently in people who are native to North and South America. Researchers want to know more about the gene changes and other factors that may cause autoimmune diseases among these people. This project will be based in Peru.

Objective:

To study how gene changes can lead to autoimmune diseases in people native to Peru.

Eligibility:

People aged 18 years and older with an autoimmune disease. These may include systemic lupus erythematosus; Sjogren disease; scleroderma; rheumatoid arthritis; seronegative spondylo-arthropathies; and systemic vasculitis. Family members and healthy volunteers are also needed.

Design:

Participants will have 2 clinic visits; these will be 2 weeks apart. The clinics will be in Lima, Iquitos, and other sites in Peru.

Visit 1: Participants will have a physical exam. They will answer questions about their health risks and habits. They will provide blood and urine samples.

Visit 2: Participants will provide a second blood sample and a stool sample. They will talk about the results of their first clinical exam with researchers.

The cost of travel to and from the clinics will be provided. Participants will get $30 per visit and a snack.

Exclusion: -People diagnosed with a chronic viral disease: HIV, hepatitis C or HTLV-1.

INCLUSION CRITERIA:; Any person who meets the criteria for inclusion in the study will be considered and must have the patient's signed informed consent for participation; Autoimmune Disease Diagnosis:; Cases:; Patients diagnosed with SLE, Sjogren's disease, scleroderma, rheumatoid arthritis, seronegative spondyloarthropathies, and systemic vasculitis, as defined by the American College of Rheumatology classification criteria; Over 18 years old; Controls:; Family members of identified cases, and unrelated individuals. The controls would be from the same community as the patients and families studied, and of the same age and gender. Screening for autoimmune diseases and allergic diseases will be performed; Over 18 years old.

ClinicalTrials.gov NCT06948110